Zai Lab (ZLAB) Gross Margin (2020 - 2026)

Zai Lab's (ZLAB) quarterly Gross Margin came in at 61.54% in Q1 2026, down 1517.0% year-on-year from 4.34% in Q1 2025, and down 60.97% quarter-over-quarter from 157.65% in Q4 2025.

Zai Lab (ZLAB) Gross Margin (2020 - 2026) Analysis & Trends

Zai Lab has disclosed Gross Margin across 7 years of filings, most recently posting 61.54% for Q1 2026.

  • Gross Margin for Q1 2026 came in at 61.54%, down 1517.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4895.3% (up 469629.0% YoY), and the FY2025 annual result was 6250.67%, up 415776.0% from the prior year.
  • Gross Margin came in at 61.54% for Q1 2026 at Zai Lab, down from 157.65% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 252.58% in Q4 2023 to a low of 8687.0% in Q2 2024.
  • The 5-year median for Gross Margin is 71.61% (2022), against an average of 525.74%.
  • Across the five-year window, Gross Margin tumbled 10160 bps in 2024 and soared 878680 bps in 2025, its largest moves.
  • Zai Lab's Gross Margin stood at 66.27% in 2022, then jumped by 281 bps to 252.58% in 2023, then plunged by 40 bps to 150.99% in 2024, then advanced by 4 bps to 157.65% in 2025, then tumbled by 61 bps to 61.54% in 2026.
  • The last three Gross Margin figures came in at 61.54% (Q1 2026), 157.65% (Q4 2025), and 99.9% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn 61.54%

Historic Data

Download Data
DateValue
Mar 31, 2026 61.54%
Dec 31, 2025 157.65%
Sep 30, 2025 99.90%
Jun 30, 2025 99.80%
Mar 31, 2025 76.70%
Dec 31, 2024 150.99%
Sep 30, 2024 99.66%
Jun 30, 2024 -8,687.00%
Dec 31, 2023 252.58%
Mar 31, 2023 66.02%
Dec 31, 2022 66.27%
Sep 30, 2022 65.17%
Jun 30, 2022 63.87%
Mar 31, 2022 66.52%
Dec 31, 2021 50.63%
Mar 31, 2021 62.67%
Dec 31, 2020 54.80%
Sep 30, 2020 66.32%
Jun 30, 2020 73.66%
Mar 31, 2020 74.64%